Article info
PDFCase Reports: Novel treatment (new drug/interventions; established drug/procedure in new situation)
Successful novel use of tofacitinib for type II refractory coeliac disease
- Correspondence to Dr Jasleen Kaur Grewal; jkgrewal001{at}gmail.com
Citation
Successful novel use of tofacitinib for type II refractory coeliac disease
Publication history
- Accepted March 25, 2022
- First published April 13, 2022.
Online issue publication
April 13, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.